PROCESS FOR PREPARING FLUORINATED COMPOUNDS AND PRODUCTS OBTAINABLE THEREBY

Abstract: The present invention provides a process for preparing fluo­ rinated compounds of general formulae: XH-Y-(CF₂) n -CZ₁Z₂F (I) and YH-X-(CF₂) n -CZ₁Z₂F (II) wherein: X and Y, different from each other, both represent R x ,O,S, CFR x , C(R x )₂ or CF₂; R x is a perhalogenated alkyl group containing from 1 to 4 carbon atoms; n is 0 or 1; Z₁ and Z₂, the same or different from each other, represent F, Cl, Br, H or R x . Said process is characterized in that a fluorinated cyclic compound of formula is reacted, at a temperature of from about -80°C to about +300 °C, with HF in the presence of a Lewis acid. Some of the resulting products are novel compounds.

Description: The present invention relates to a process for the preparation of fluorinated compounds, as well as to novel fluorinated compounds obtainable by means of said process. US-A-4 010 212 discloses the preparation of perfluorinated tertiary alcohols from perfluoro-isoalkylene oxides-1,2 by reacting these cyclic ethers with HF in the presence of a Lewis acid. The synthesis of trifluoromethyl amines CF₃NHR (R = F, OCF₃, OCF(CF₃)₂, OMe, OEt, OCHMe₂, OCMe₃, OAc) by hydrolysis of CF₃NRCOF in the presence of NaF has been reported by A. Sekiya and D. Desmarteau (Chemical Abstracts 93 , page 904). The present invention relates to a process for the preparation of fluorinated compounds having the formula: XH-Y-CZ₁Z₂-(CF₂) n -F (I) and YH-X-(CF₂) n -CZ₁Z₂F (II) wherein: X is NR x , O, S, CFR x , (CR x )₂ or CF₂; Y is NR x , O, S, CFR x , (CR x )₂ or CF₂; X is different from Y; R x is a perhalogenated alkyl group containing from 1 to 4 carbon atoms; n is either 0 or 1, with the proviso that when n = 0, X = NR x ; Z₁ and Z₂, the same or different from each other, represent F, Cl, Br, H or R x , which process is characterized in that a fluorinated cyclic compound of formula: is reacted, at a temperature of from about -80°C to about +300°C, preferably from about 0°C to about 100°C, with HF in the presence of a Lewis acid. In the process of the present invention, particularly preferred compounds of formula (III) are those wherein X (or Y) is NR x , C(R x )₂ CFR x and CF₂ and Y (or X) is 0. n preferably is 1 while preferred meanings of Z₁ and Z₂ are H, F and Cl. R x preferably is selected from C₁- and C₂-perhaloalkyl groups, particularly CF₃ and C₂F₅. When there is more than one group R x , said groups R x can be the same or different from each other. Preferred halogen atoms present in R x are F and Cl, particularly F. The Lewis acid is preferably selected from AsF₅, SbF₅ and BF₃. The most preferred Lewis acid is AsF₅. At the end of the reaction, the Lewis acid and any excess HF are separated from the end product, preferably by neutralization with a neutralizing agent. As the neutralizing agent, compounds such as NaF, KF, KHF₂, RbF or CsF can be used, NaF being the preferred one. The molar ratio of HF to the florinated cyclic compound (III) usually ranges from about 2:1 to about 50:1, preferably from about 4:1 to about 25:1. The molar ratio of the Lewis acid (e.g. AsF₅) to the fluorinated cyclic compound of formula (III) generally is from about 0.1:1 to about 5:1 and preferably of from about 1:1 to about 2:1. The reaction is usually complete within 30 minutes to 3 days and, more commonly, within 1 hour to 36 hours. At the end of the reaction, the reaction mixture is preferably treated with a neutralizing agent, in order to neutralize any unreacted HF and the Lewis acid. This neutralization step can usually be accomplished at a temperature of from about -20°C to about +50°C, and preferably from about +20°C to about +25°C. In general, an excess of neutralizing agent is employed: this excess usually is within the range of from about 2 to about 10 mol, preferably from about 3 to about 5 mol, of neutralizing agent (e.g. NaF), per each mol of the sum of the starting HF plus the Lewis acid. This neutralization step usually is completed within 30 minutes to 30 days. In the fluorinated cyclic compound of formula (III) used as the starting material and in the fluorinated compounds of formulae (I) and (II) obtained, R x preferably is a perfluorinated alkyl group. According to the structure of the starting cyclic compound of formula (III) and, in particular, according to the nature of X and of Y and of the substituents Z₁ and Z₂, the product of formula (I) or the product of formula (II), or both of them, will be obtained, as will be explained in the following with reference to specific cases. When X in the compound of formula (II) represents CR x F or CF₂, said product will eliminate HF to yield the unsaturated compounds of the following formulae: Y=CR x -(CF₂) n -CZ₁Z₂F or Y=CF-(CF₂) n -CZ₁Z₂F. According to a preferred embodiment of the present invention, the cyclic compound used as the starting compound has the formula: and the end products are: the amines of formula R x -NH-O-CZ₁Z₂-CF₃ (V) and the hydroxylamines of formula R x -NOH-CF₂-CZ₁Z₂F (VI) The amines of formula (V) are new compounds. They are useful intermediates, in particular for the preparation of the corresponding N-fluorinated amines of formula: R x -NF-O-CZ₁Z₂-CF₃ (VII) which are suitable as catalysts for the polymerization of C₂F₄. The compounds of formula (VII) are also novel and constitute a further object of the present invention. The N-fluorinated compounds of formula (VII) can be obtained by means of the reaction of the amines of formula (V) with F₂ at a temperature in the range of from about -195°C to about 5°C, preferably of from about -100°C to about 0°C. The molar ratio of F₂ to the amine usually ranges from about 1:1 to about 2:1, preferably of from about 1.0:1 to about 1.3:1. The preferred amines of formula (V) and N-fluorinated amines of formula (VII) are those in which R x is CF₃. Z₁ is F and Z₂ is F, Cl or H. These preferred compounds are: CF₃-NH-O-CF₂CF₃ (VIII) N-(pentafluoroethoxy)-trifluoromethyl-amine; CF₃-NH-O-CFCl-CF₃ (IX) N-(1-chloro-1,2,2,2-tetrafluoroethoxy)-trifluoromethyl-amine; CF₃-NH-O-CHF-CF₃ (X) N-(1,2,2,2-tetrafluoro-ethoxy)-trifluoromethyl-amine; CF₃-NF-OCF₂CF₃ (XI) N-fluoro-N-(pentafluoroethoxy)-trifluoromethyl-amine; CF₃-NF-O-CFCl-CF₃ (XII) N-fluoro-N-(1-chloro-1,2,2,2-tetrafluoroethoxy)-trifluoromethyl-amine; CF₃-NF-O-CFH-CF₃ (XIII) N-fluoro-N-(1,2,2,2-tetrafluoroethoxy)-trifluoromethyl-amine. The possibility of obtaining, in some cases, the amines of formula (V), and, in other cases, a mixture of amines (V) and hydroxylamines of formula (VI), when as starting material cyclic compounds of formula (IV) are used, is illustrated by the following equations (1) and (2). According to another preferred embodiment of the present invention, the cyclic compound used as the starting compound is: and the end product is R x -NH-O-CF₃ (XV) According to a still further preferred embodiment of the present invention, the cyclic compound used as the starting compound is: wherein R¹ and R², the same or different from each other, are F or R x ; and the end product is: The following examples are given in order to illustrate the present invention without, however, being a limitation thereof. EXAMPLE 1 This example illustrates the reaction: The perfluorinated oxazetidine (XVIII) used as the starting material was prepared from CF₃-N=O and CF₂=CF₂ (Barr D.A. et al, J. Chem. Soc., 1955, 1881-1889). The reaction vessel was assembled by heat-sealing one end of a Teflon®-FEP tube of 5/8" outside diameter and 1/2" internal diameter. The other end of the tube was inserted in a 5/8"-1/2" stainless-steel reducing unit, which, in its turn, was connected to a stainless-steel valve through a 1/2"-1/4" stainless-steel reducing port connector. The internal volume of the reactor was 39.5 ml. An insert of stainless steel was placed inside the open end of the tubular FEP reactor as support. The FEP reactor was evacuated 15 µm Hg; all of the subsequent manipulations under vacuum were carried out under this pressure) and weighed. The reactor was cooled to -196°C, and anhydrous HF was condensed therein by static vacuum, through a stainless-steel manifold. The reactor was heated to 23°C, and was weighed again: the amount of HF was determined through the weight difference, and amounted to 0.97 g (48 mmol). The reactor was cooled again with liquid nitrogen, and AsF₅ (10.0 mmol) was condensed therein by static vacuum, through a Pyrex®-glass manifold. The reactor was heated again to 23°C, while being stirred in order to mix HF and AsF₅. After cooling the reactor again down to -196°C, the above perfluorinated oxazetidine of formula (XVIII) (5.00 mmol) was condensed under static vacuum, through a vacuum glass line. The mixture was heated with stirring to room temperature; a vigorous reaction started as soon as the mixture began to melt. The reaction was allowed to proceed at 23°C for 18 hours. The reactor was then degassed by pumping off the gases which could not be condensed at -196°C; this operation facilitated the subsequent step of vacuum transfer. After degassing at -196°C, the reaction mixture was heated to 23°C and volatile matter was condensed, via static vacuum, through a stainless-steel manifold, in a 150 ml reaction tank, equipped with a stainless-steel valve, cooled with liquid nitrogen and containing 12.22 g (291 mmol) of NaF powder (in order to remove HF and AsF₅) and also several stainless-steel balls having a diameter of 3/8". By heating the reactor (to about 100°C) and stirring for about 20 minutes the transfer of components to the tank could be accomplished. After 2.5 hours at 23°C, with intermittent shaking, any volatiles contained in the reaction tank were slowly pumped into a Pyrex®"U"-trap cooled with liquid nitrogen. The subsequent fractionation of this material under dynamic vacuum, through a series of "U"-traps cooled at -70°C, -95°C and -196°C, afforded 4.84 mmol of compound of formula CF₃-NH-OCF₂CF₃ inside the trap at -95°C (yield 96.8%, relative to oxazetidine (XVIII)). CF₃-NH-OCF₂CF₃ showed the following spectra: IR (3 torr): 3342 ( N-H,m), 1483 (sh,w), 1453 (s), 1399 (w), 1313 (vs), 1275 (sh,m), 1236 (vs), 1197 (vs), 1170 (vs), 1107 (vs), 1028 (w), 969 (w), 919 (m), 863 (m), 814 (w), 741 (m), 679 (w), 620 (w), 569 (w) cm⁻¹; (m = medium; sh= shoulder; w = weak; s = strong, vs = very strong.) NMR : CF₃ A N(H)-OCF₂ B CF₃ C δ ¹H (CDCl₃) 6.6 (br q), ¹⁹F (CDCl₃) A -70.6 (3F, d-t), B -95.3 (2F, q-q), C -84.9 ppm (3F, t), J HA = 8.6; J AB = 3.8; J BC = 1.7; J HB = J HC = J AC = 0 Hz. Mass spectrum : major peaks, m/z [EI]: 219 (M+); 200 (M-F⁺); 180 (M-F-HF⁺); 130 (M-HF-CF₃⁺); 119 (CF₃CF₂⁺); 69 (CF₃⁺) major peaks m/z [CI]: 200 (M+1⁺); 200 (M+1-HF⁺); 180 (M+1-2HF⁺); 130 (M-HF-CF₃⁺); 119 (CF₃CF₂⁺). EXAMPLE 2 This example illustrates the reaction: Oxazetidine (XIX) was prepared by thermal cycloaddition of CF₃-N=O and CF₂=CHF (Banks R.E. et al, J. Chem. Soc., 2506-2513, 1965). The general procedure of example 1 was followed, using a reactor having an internal volume of about 35 ml. The following materials were introduced: 1.73 g of anhydrous HF (86 mmol); 10.00 mmol of AsF₅; 5.00 mmol of oxazetidine (XIX). The mixture was heated with stirring to room temperature; a vigorous reaction started as soon as the mixture began to melt. The reaction was allowed to proceed at 23°C for 24 hours. The neutralization was carried out with 18.16 g (432 mmol) of NaF powder. After vacuum fractionation, 3.20 mmol of compound of formula CF₃-NH-OCHF-CF₃ were obtained in the trap at -90°C (yield 64.0%, relative to oxazetidine). CF₃-NH-OCHF-CF₃ showed the following spectra: IR (3 torr) : 3335 ( N-H,m); 2989 ( C-H,w); 1478 (sh,w); 1433 (s); 1409 (w); 1344 (w); 1291 (vs); 1214 (vs); 1191 (vs); 1127 (vs); 1088 (s); 1021 (w); 989 (sh,w); 923 (m); 904 (m); 830 (w); 725 (m); 700 (m); 609 ( w); 563 (w) cm⁻¹. NMR : CF₃ A N(H B )-OCH C F D CF₃ E δ ¹H (CDCl₃) B 6.7 (1 H, br q); C 5.7 (1 H, d-q); δ ¹⁹F (CDCl₃) A -71.2 (3F, d-d); D -144.8 (1F, d-q-q); E -82.6 ppm (3F, d-d); J AB = 8.4; J AD = 2.2; J CD = 57.6; J CE = 3.2; J DE = 5.9; J AC = J AE = J BC = J BD = J BE = 0 Hz. Mass spectrum : major peaks m/z [EI]: 201 (M⁺); 1.82 (M-F⁺); 162 (M-F-HF⁺); 132 (M-CF₃⁺); 112 (M-CF₃-HF⁺); 101 (CF₃CHF⁺); 100 (CF₃CF⁺); 69 (CF₃⁺); major peaks m/z [CI] : 202 (M+1⁺): 182 (M+1-HF⁺). EXAMPLE 3 This example illustrates the reaction: Oxazetidine (XX) was prepared from CF₃-N=O nad CF₂=CFCl (Barr D.A. et al, J. Chem. Soc., 1961, 1351-1362). The general procedure of example 1 was followed, using a reactor having an internal volume of 18 ml. The following materials were introduced: 2.5 mmol of anhydrous HF; 3.7 mmol of AsF₅; 1.22 mmol of oxazetidine (XX). The mixture was heated to 25°C. No reaction appeared to take place at once, but after shaking for about 5 minutes the two liquid phases, initially immiscible, became homogeneous. The mixture was left standing at 25°C for 18 hours. The neutralization was carried out with 10.28 g (245 mmol) of NaF powder. After the vacuum fractionation, a trap at -60°C contained 0.25 mmol of compound of formula CF₃-NOH-CF₂-CF₂Cl (yield 20%, relative to oxazetidine), and a trap at -111°C contained 0.78 mmol of CF₃-NH-OCFCl-CF₃ (yield 64%). CF₃-NH-O-CFCl-CF₃ showed the following spectra: IR (4 torr) : 3333 (N-H, m); 1489 (sh,w); 1450 (s); 1336 (s); 1308 (vs); 1279 (sh,m); 1228 (vs); 1206 (sh,s); 1149 (s); 1126 (s); 1093 (vs); 1022 (m); 993 (s); 918 (m), 874 (w); 839 (m); 654 (w); 563 (w) cm⁻¹. NMR : CF₃ A N(H)-OCF B ClCF₃ C δ ¹H (CDCl₃) 6.6 (br q); δ ¹⁹F (CDCl₃) A -69.9 (3F, d-d); B -81.3 (1F, q-q); C -83.1 ppm (3F, d); J HA = 8.5; J AB = 4.1; J BC = 2.4; J HB = J HC = J AC = 0 Hz. Mass spectrum : major peaks m/z [EI]: 200 (M-Cl⁺); 180 (M-Cl-HF⁺); 135/137 (CFClCF₃⁺); 85/87 (CF₂Cl⁺); 69 (CF₃⁺); major peaks m/z [CI]: 236/238 (M+1⁺); 216/218 (M+1-HF⁺); 200(M-Cl⁺); 180 (M-Cl-HF⁺); 135/137 (CFClCF₃⁺). EXAMPLE 4 This example illustrates the reaction: Oxetane (XXI) was prepared by photochemical addition of hexafluoro-acetone and C₂F₄ (FR-A-1,391,493). The general procedure of example 1 was followed, using a reactor having an internal volume of 12 ml. The following materials were introduced: 2.07 g (9.55 mmol) of SbF₅; 2.21 g (110 mmol) of anhydrous HF; 9.55 mmol of oxetane (XXI). The reactor was heated to 23°C whereupon the mixture still formed two liquid phases, with no indication of a reaction taking place. The reactor was then heated to 55°C for 17 hours, whereafter the mixture had become homogeneous. The neutralization was carried out with 23.19 g (553 mmol) of NaF powder. The vacuum fractionation yielded 9.20 mmol of compound of formula CF₃CF₂C(CF₃)₂-OH inside a trap at -80°C (yield 96.3%, relative to the oxetane). EXAMPLE 5 This example illustrates the preparation of CF₃-NF-OCF₂-CF₃ (XI) by fluorination of CF₃-NH-OCF₂CF₃. In all of the process steps carried out under vacuum the vacuum was 5 µm Hg. The reactor consisted of a 150 ml stainless-steel reaction tank, equipped with a stainless-steel valve and previously passivated with 1 atm of F₂ for 18 hours at 23°C. The reaction tank was evacuated, cooled to -196°C, and CF₃-NH-OCF₂CF₃ (2.50 mmol) was condensed under static vacuum through a Pyrex® glass vacuum line. F₂ was introduced into the reaction tank, at -196°C, through a vacuum line of stainless steel; a 5% excess of F₂ was present (2.62 mmol of total F₂). The liquid nitrogen used to cool the tank was removed from the Dewar bottle and the tank was allowed to slowly warm inside the empty Dewar bottle. The temperature increased from -196°C to about +5°C during 23.5 hours; thereafter the reaction tank was cooled again down to -196°C, and a trace of unreacted F₂ was pumped off into the stainless-steel vacuum line. After heating the reaction tank to 23°C, volatile matter was condensed via static vacuum through the stainless-steel manifold into a 75 ml Hoke tank of stainless steel, cooled with liquid nitrogen, containing 2.01 g (47.9 mmol) of NaF powder, in order to remove HF. The NaF-containing tank was equipped with a stainless-steel valve, and the tank, already containing NaF, had previously been passivated with 1 atm of F₂ for 6 hours at 23°C. The volatile matter transferred was left standing over NaF for 18 hours at 23°C. The contents of the NaF-containing tank were then carefully pumped out and collected in a "U"-shaped trap of Pyrex® glass, cooled at -196°C. The fractionation under dynamic vacuum through a series of traps at temperatures of -90°C, -135°C and -196°C yielded 2.46 mmol of compound of formula CF₃-NF-OCF₂CF₃ inside the trap at -135°C (yield 98.4%, relative to CF₃ -NH-OCF₂CF₃ ). CF₃ -NF-OCF₂CF₃ showed the following spectra: IR (4 torr): 2304 (vw); 1400 (w); 1277 (vs); 1243 (vs); 1209 (sh,s); 1193 (vs); 1098 (vs); 998 (m); 932 (m); 889 (m); 826 (vw); 753 (w); 696 (m); 655 (w); 604 (vw); 531 (vw) cm⁻¹; NMR : CF₃ C N(F D )-OCF A F B CF₃ E ¹⁹F (CDCl₃, 23°C) A -93.3 (1F, m); B -95.6 (1F, m); C -81.1 (3F, br s); D +10.5 (1F, br s); E -84.9 ppm (3F, q); J AB = 142.1; J AC = 1.7; J AD = 5.2; J AE = 1.7; J BD = 7.4; J BE = 1.7; J CD = 1.5; J DE = 1.6; J BC = J CE = 0 Hz. Mass spectrum : major peaks m/z [EI]: 119 (C₂F₅⁺); 69 (CF₃⁺); 50 (CF₂⁺); major peaks m/z [CI]: 238 (M+1⁺); 218 (M+1-HF⁺); 130 (CF₂NOCF₂⁺); 119 (C₂F₅⁺). EXAMPLE 6 This example illustrates the polymerization of C₂F₄, catalyzed by CF₃-NF-OCF₂CF₃. C₂F₄ (PCR, Inc.) was washed, in order to remove the polymerization inhibitor (d-limonene, boiling point 178°C), by causing it to flow through a trap cooled at -111°C, under dynamic vacuum conditions. The no longer inhibited C₂F₄ was collected inside a trap at -196°C. This operation, as well as all subsequent operations carried out under vacuum, was conducted under a vacuum of 5 µm Hg. Inhibitor-free C₂F₄ (2.00 mmol) and CF₃-NF-OCF₂CF₃ (0.20 mmol) were condensed via static vacuum inside a Pyrex®-glass tube cooled with liquid nitrogen; the tube had an internal volume of 48.8 ml and was equipped with a glass/Teflon® stopcock. The tube and its contents were allowed to warm up to 23°C, and were heated, by using a heating tape, at 150°C for 12 hours. After cooling to room temperature and after removing the heating tape, the tube was found to contain a soft fluffy mass constituted by a white solid. The residual volatile matter was carefully pumped off and collected inside a liquid-nitrogen trap. No non-condensable gases could be detected. The PTFE remaining inside the reaction tube weighed 140 mg, by weight difference, and represented 1.40 mmol, i.e., 70% of the tetrafluoroethylene initially employed. The fractionation of the residual volatile matter, by operating under dynamic vacuum conditions, through traps cooled at -135°C and at -196°C, yielded 0.21 mmol of material inside the trap at -135°C; the IR spectrum of said material indicated that it was constituted by the catalyst of formula CF₃-NF-OCF₂CF₃ (quantitative recovery). The trap at -196°C contained 0.55 mmol of C₂F₄, i.e., 27.5% of the olefin initially employed.

Claims: Process for the preparation of fluorinated compounds of general formulae XH-Y-CZ₁Z₂-(CF₂) n -F (I) and YH-X-(CF₂) n -CZ₁Z₂F (II) wherein: X and Y, which are different from each other, both may represent NR x , O, S, CFR x , C(R x )₂ or CF₂; R x is a perhalogenated alkyl group containing from 1 to 4 carbon atoms; n is 0 or 1, with the proviso that when n = 0, X = NR x ; Z₁ and Z₂, the same or different from each other, represent F, Cl, Br, H or R x , characterized in that a fluorinated cyclic compound of formula: wherein X, Y, R x , n, Z₁ and Z₂ are defined as above, is reacted, at a temperature of from about -80°C to about 300°C, with HF in the presence of a Lewis acid. Process according to claim 1, characterised in that the Lewis acid is selected from fluorinated Lewis acids, particularly AsF₅, SbF₅ and BF₃. Process according to any of claims 1 and 2, characterized in that at the end of the reaction, the Lewis acid and any excess HF are separated from the end product by neutralization with a neutralizing agent. Process according to one or more of the preceding claims, characterized in that the reaction is carried out at a temperature of from about 0°C to about 100°C. Process according to one or more of the preceding claims, characterized in that R x is a perfluorinated alkyl group. Process according to one or more of the preceding claims, characterized in that the fluorinated cyclic compound has the formula: and the end products have the formulae: R x -NH-O-CZ₁Z₂-CF₃ (V) and R x -NOH-CF₂-CZ₁Z₂F; (VI) or the fluorinated cyclic compound has the formula: and the end product has the formula: R x -NH-O-CF₃; (XV) or the fluorinated cyclic compound has the formula: wherein R¹ and R², the same or different from each other, are F or R x , and the end product has the formula: R x , Z₁ and Z₂ being defined as in any one of claims 1 and 5. N-Perhaloalkyl-alkoxyamines having the general formula: R x -NH-O-CZ₁Z₂-CF₃ (V) wherein: R x is a perhalogenated alkyl group containing from 1 to 4 carbon atoms; Z₁ and Z₂, the same or different from each other, represent F, Cl, Br or H. Compounds according to claim 7, wherein R x is a perfluorinated alkyl group, and particularly compounds of the following formulae (VIII) to (X): CF₃-NH-O-CF₂CF₃ (VIII) CF₃-NH-O-CFClCF₃ (IX) CF₃-NH-O-CHFCF₃ (X) N-Fluoro-N-perhaloalkyl-alkoxy-amines of general formula: R x -NF-O-CZ₁Z₂-CF₃ (VII) wherein: R x is a perhalogenated alkyl group, containing from 1 to 4 carbon atoms; Z₁ and Z₂, the same or different from each other, represent F, Cl, Br, H or R x . Compounds according to claim 9, wherein R x is a perfluorinated alkyl group, and particularly compounds of the following formulae (XI) to (XIII): CF₃-NF-O-CF₂CF₃ (XI) CF₃-NF-O-CFClCF₃ (XII) CF₃-NF-O-CHFCF₃ (XIII)

Inventors: DESMARTEAU, DARRYL D., DR., KOTUN, STEFAN P., DR., MALACRIDA, ALESSANDRO, DR.
Applicants: AUSIMONT S.R.L.
Application year: 1989
Main classification: C07B39
IPC codes: C07C19, C07C323, C07B39, C07C31, C07C313, C07C17, C07C43, C07B61, C07C239, C07C29, C07C211, C07C209